Page last updated: 2024-10-24

carvedilol and Degenerative Diseases, Central Nervous System

carvedilol has been researched along with Degenerative Diseases, Central Nervous System in 4 studies

Research Excerpts

ExcerptRelevanceReference
" The dose-response relationship between the administered beta blockers and respiratory rates was examined using multivariable regression models."1.91Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study. ( Nagamine, T; Takayama, A; Yoshioka, T, 2023)
"Carvedilol is an adrenergic receptor antagonist."1.91Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination. ( Ahmed, KA; Ibrahim Fouad, G, 2023)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Takayama, A1
Yoshioka, T1
Nagamine, T1
Ibrahim Fouad, G1
Ahmed, KA1
Saeidnia, S1
Abdollahi, M1
Mason, RP1
Cockcroft, JR1

Reviews

2 reviews available for carvedilol and Degenerative Diseases, Central Nervous System

ArticleYear
Toxicological and pharmacological concerns on oxidative stress and related diseases.
    Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; B

2013
Targeting nitric oxide with drug therapy.
    Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:12 Suppl 4

    Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzopyrans

2006

Other Studies

2 other studies available for carvedilol and Degenerative Diseases, Central Nervous System

ArticleYear
Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study.
    Pulmonary pharmacology & therapeutics, 2023, Volume: 78

    Topics: Adrenergic beta-Antagonists; Aged; Carvedilol; Cross-Sectional Studies; Heart Failure; Humans; Neuro

2023
Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination.
    International immunopharmacology, 2023, Volume: 118

    Topics: Animals; Carvedilol; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice; Mice, Inbred C

2023